FIELD: medicine.
SUBSTANCE: invention concerns experimental medicine and can be used for modelling of an acute pyelonephritis. For this purpose the top third of ureter is narrowed for 2/3 of the initial diametre in an intraoperative manner. Then the centre of an aseptic necrosis in parenchyma of kidney is created by introduction of 0.5 ml of 10% calcium chloride solution with bacteriemic culture entered under the ultrasonic control. As a bacteriemic culture suspension of golden staphilococcus from calculation of 104 microbic bodies of 1 ml in a dose of 1 ml is used.
EFFECT: adequate reproduction of model.
7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MODELING PYELONEPHRITIS | 2004 |
|
RU2289852C2 |
| METHOD FOR ACUTE GESTATIONAL PYELONEPHRITIS SEVERITY EVALUATION DUE TO VESICOURETERAL REFLUX | 2021 |
|
RU2760885C1 |
| METHOD FOR SIMULATING KIDNEY TUBERCULOSIS | 2021 |
|
RU2776130C1 |
| METHOD OF TREATMENT OF PATIENTS ILL WITH CHRONIC PYELONEPHRITIS | 0 |
|
SU1107866A1 |
| METHOD OF ASSESSING RENAL PARENCHYMA REMODELLING PROCESS AFTER RESOLUTION OF OBSTRUCTION IN UROLITHIASIS | 2019 |
|
RU2735812C1 |
| METHOD FOR PREVENTION OF SEVERE COURSE OF GESTATIONAL PYELONEPHRITIS CAUSED BY VESICOURETERAL REFLUX | 2021 |
|
RU2757585C1 |
| METHOD FOR TREATING PATIENTS FOR PURULENT PYELONEPHRITIS | 2002 |
|
RU2226074C1 |
| METHOD FOR DETERMINING THE LENGTH OF LITHOTRIPSY FOLLOWING RESOLUTION OF OBSTRUCTION IN UROLITHIASIS | 2019 |
|
RU2723245C1 |
| SURGICAL METHOD FOR TREATING PURULENT DESTRUCTIVE FORMS OF PYELONEPHRITIS | 2001 |
|
RU2202962C2 |
| METHOD FOR PERCUTANEOUS NEPHROLITHOTOMY | 2015 |
|
RU2574573C1 |
